Importantly, RBP4 secretion by the PPAT has not yet been evaluated and the possible effects of RBP4 on PCa and in the context of metabolic dysfunction-associated prostatic neoplasm formation is largely uninvestigated. This evidence concerns the gene RBP4 and posterior cortical atrophy.